Sfoglia per Rivista  VALUE IN HEALTH

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 1 a 10 di 10
Titolo Data di pubblicazione Autore(i) File
Cost-effectiveness of peginterferon α-2a (40 KD) for the treatment of chronic hepatitis B in Italy 2006 Eandi M; Iannazzo S; Pradelli L; Patel K; Giuliani G.
Cost-effectiveness of preventing recurrent upper respiratory tract infections with a non-specific immunostimulating bacterial extract 2005 Zaniolo O; Pradelli L; Eandi M.
Development of a Prediction Model of Disease Activity in Support of Clinical Practice - the Acrodat Experience 2015 Pleil, A; van der Lely, A J; Badia, X; Brue, T; Buchfelder, M; Burman, P; Ghigo, E; Gomez, R; Jorgensen, J O; Luger, A; van der Lans-Bussemaker, J; Webb, S; Strasburger, C
Economic Efficiency of Countries’ Clinical Review Processes and Competitiveness on the Market of Human Experimentation 2013 Roberto Ippoliti
Information on center characteristics as costs' determinants in Multicenter clinical trials: Is modeling center effect worth the effort? 2009 PETRINCO M; PAGANO E; DESIDERI A; BIGI R; GHIDINA M; FERRANDO A; CORTIGLIANI L; MERLETTI F; GREGORI D
Inhaled corticosteroids and bronchodilators for severe and very severe COPD patients: cost-effectiveness and health care budget impact in Italy 2005 Pradelli L; Iannazzo S; Dal Negro RW; Eandi M.
PCN350 - EVALUATION OF DISEASE-SPECIFIC SKIN SYMPTOM ITEMS ON SKINDEX-29 IN CUTANEOUS T-CELL LYMPHOMA PATIENTS TREATED WITH MOGAMULIZUMAB OR VORINOSTAT 2018 QUAGLINO, P
Prevention with picotamide and aspirin in patients with type 2 diabetes mellitus and peripheral arterial disease: a pharmacoeconomic evaluation 2006 Eandi M; Iannazzo S; Pradelli L.
THE RISK OF METABOLIC DISORDERS IN PATIENTS TREATED WITH ASENAPINE OR OLANZAPINE: A REAL WORLD DATA STUDY CONDUCTED IN ITALY AND SPAIN 2014 Maina, Giuseppe; Ripellino, C; Pegoraro, V; Caresano, C.
The Application Of Health Tecnology Assessment On The New Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine In Italy. 2009 La Torre G; Capri S; Castiglia P; Anessi Pessina E; Sacchini D; Marocco A; Gualano MR; Mannocci A; Nicolotti N; Ricciardi W
Mostrati risultati da 1 a 10 di 10
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile